Product Description

🔹 Product Overview

Fulzos 250 mg/5 mL Injection contains Fulvestrant 250 mg, a selective estrogen receptor degrader (SERD) used in the treatment of certain hormone receptor-positive breast cancers.
It is administered as a deep intramuscular injection by a qualified healthcare professional.

🔹 Composition
Active Ingredient: Fulvestrant
Strength: 250 mg/5 mL
Dosage Form: Injection
Route: Intramuscular (IM)
Therapeutic Class: Antineoplastic / Hormonal therapy


🔹 Uses And Indications
Fulzos may be prescribed for:
Hormone receptor-positive (HR-positive) advanced breast cancer
Metastatic breast cancer
Certain HR-positive, HER2-negative breast cancers according to the oncologist's treatment plan
It may be used alone or in combination with other targeted anticancer medicines.

🔹 How It Works
Fulvestrant binds to estrogen receptors on breast cancer cells, blocking estrogen signaling and promoting degradation of the estrogen receptors. This reduces estrogen-dependent stimulation of tumor growth.

🔹 Key Benefits
Provides targeted hormonal treatment for appropriate HR-positive breast cancer.
Blocks estrogen-receptor signaling.
Helps slow the progression of estrogen-dependent cancer cells.
Available as a long-acting intramuscular formulation.

🔹 Dosage And Administration
Fulzos must be administered by a doctor or trained healthcare professional.
The commonly used fulvestrant regimen consists of administration on days 1, 15 and 29, followed by once-monthly dosing, although the exact treatment schedule is determined by the treating oncologist.
It is generally administered as two intramuscular injections, one into each buttock.

🔹 Common Side Effects
Possible side effects include:
Injection-site pain or inflammation
Nausea
Headache
Fatigue or weakness
Hot flushes
Joint and muscle pain
Back pain
Increased liver enzymes

🔹 Precautions And Warnings
Use only under specialist oncology supervision.
Inform the doctor about liver disease, bleeding disorders, low platelet counts, or use of anticoagulants.
Fulvestrant may harm an unborn baby and should not be used during pregnancy unless specifically directed by a specialist.
Report unusual bleeding, severe allergic reactions, significant swelling, chest pain, or breathing difficulty immediately.
Store refrigerated at 2–8°C and do not freeze.